Sphingosine 1-phosphate and cancer
Copyright policy )Sphingosine 1-phosphate and cancer
There is substantial evidence that sphingosine 1-phosphate (S1P) is involved in cancer. S1P regulates processes such as inflammation, which can drive tumorigenesis; neovascularization, which provides cancer cells with nutrients and oxygen; and cell growth and survival. This occurs at multiple levels and involves S1P receptors, sphingosine kinases, S1P phosphatases and S1P lyase. This Review summarizes current research findings and examines the potential for new therapeutics designed to alter S1P signalling and function in cancer.
- University of Strathclyde United Kingdom
- Strathclyde Institute of Pharmacy and Biomedical Sciences United Kingdom
Immunology, 610, Sphingosine, Neoplasms, Animals, Humans, Therapeutics. Pharmacology, Neoplasms. Tumors. Oncology (including Cancer), Lysophospholipids, Signal Transduction
Immunology, 610, Sphingosine, Neoplasms, Animals, Humans, Therapeutics. Pharmacology, Neoplasms. Tumors. Oncology (including Cancer), Lysophospholipids, Signal Transduction
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).770 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 0.1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 1% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 0.1%
Citations provided by BIP!Popularity provided by BIP!